May 8, 2009 - Positron Systems Inc. signed a Letter of Intent with Idaho State University (ISU) that will set the stage in a public/private partnership for the production and distribution of molybdenum-99 (99Mo), a widely used isotope in nuclear medicine.
May 8, 2009 - Preliminary data presented yesterday at the 32nd annual SCAI Scientific Sessions show that 82 percent of patients treated with Cook Medical’s Zilver PTX drug-eluting peripheral stent were free from reintervention at two-year follow up.
May 8, 2009 - ProSolv CardioVascular said Allina Hospitals and Clinics in Minneapolis, Minn., recently selected the Synapse ProSolv cardiovascular solution to become its enterprise cardiovascular system.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
May 8, 2009 - The 63rd Vascular Annual Meeting hosted by the Society for Vascular Surgery is expected to draw 1,200 of the world's top vascular surgeons June 11-12 at the Colorado Convention Center in Denver.
May 7, 2009 - The University of Illinois Medical Center, the primary teaching facility for the UIC College of Medicine, is the first such institution to install and the innovative Shape-HF Cardiopulmonary Testing System.
May 7, 2009 - GE Healthcare and Hansen Medical Inc. today said they have entered into a collaboration to promote the use of GE Healthcare’s imaging technologies and Hansen Medical’s robotic catheter technologies for electrophysiology (EP) procedures.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
May 7, 2009 - Medtronic Inc. yesterday said it completed enrollment in its investigational device exemption (IDE) study of the Endurant Stent Graft System, which is designed to enable the nonsurgical repair of aortic aneurysms. Key data from this study, now expected in the second half of 2010, will be used to support the FDA pre-market approval (PMA) submission for U.S. approval of Endurant.
May 7, 2009 - The Society of Cardiovascular Computed Tomography (SCCT) said this week a report, “Guidelines for the Performance of Coronary Computed Tomographic Angiography,” will be printed in the May/June issue of the Journal of Cardiovascular Computed Tomography that establishes a consensus of the minimally required standards for appropriate coronary CTA acquisition, as well as recommendati
May 7, 2009 - St. Jude Medical Inc. today started the U.S. launch of its Attune Flexible Adjustable Annuloplasty Ring for the repair of diseased heart valves. The company received FDA clearance and will introduce the product at the annual meeting of the American Association for Thoracic Surgery May 9 in Boston.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
May 7, 2009 - GE announced today that it will spend $3 billion over the next six years on healthcare innovation that will help deliver better care to more people at lower cost. In addition, the company will commit $2 billion of financing and $1 billion in related GE technology and content to drive healthcare information technology and health in rural and underserved areas.
GE Healthcare's CardioICE (intra-cardiac echo) is offered as a feature on the new CardioLab XTi EP recording system, released in May 2009. CardioICE synchronizes EP signal data and procedure information with real-time ultrasound images.
May 6, 2009 - GE Healthcare will introduce three new CardioLab electrophysiology (EP) recording systems to address the need for cost-effective clinical systems at the upcoming Heart Rhythm Society meeting May 13-16 in Boston.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
May 6, 2009 - Endosense said today it received the CE mark for its TactiCath system, reportedly the first force-sensing ablation catheter developed to gives physicians a real-time, objective measure of contact force during the catheter ablation procedure.
May 6, 2009 - Spectranetics Corp. yesterday said it made a pre-IDE (investigational device exemption) submission to the FDA regarding the use of laser ablation to treat in-stent restenosis (ISR) in the legs. ISR is caused by the regrowth of tissue within the stent, known as neointimal hyperplasia, which can lead to blockages in the affected leg artery.
May 6, 2009 - GE Chairman and CEO Jeff Immelt will hold a press conference at 10 a.m. Thursday, May 7, in Washington, D.C., at the Newseum, 555 Pennsylvania Ave., N.W. , to unveil GE’s new global business strategy for delivering better health care to more people at a lower cost.